OpenURL Connection Search

Select item for more details and to access through your institution.

Promotion of sleep by targeting the orexin system in rats, dogs and humans.
Published in:
Nature Medicine, 2007, v. 13, n. 2, p. 150, doi. 10.1038/nm1544
By:
- Brisbare-Roch, Catherine;
- Dingemanse, Jasper;
- Koberstein, Ralf;
- Hoever, Petra;
- Aissaoui, Hamed;
- Flores, Susan;
- Mueller, Celia;
- Nayler, Oliver;
- van Gerven, Joop;
- de Haas, Sanne L;
- Hess, Patrick;
- Qiu, Changbin;
- Buchmann, Stephan;
- Scherz, Michael;
- Weller, Thomas;
- Fischli, Walter;
- Clozel, Martine;
- Jenck, François
Publication type:
Article
An Overview of the CNS-Pharmacodynamic Profiles of Nonselective and Selective GABA Agonists.
Published in:
Advances in Pharmacological Sciences, 2012, v. 2012, p. 1, doi. 10.1155/2012/134523
By:
- Xia Chen;
- de Haas, Sanne;
- de Kam, Marieke;
- van Gerven, Joop
Publication type:
Article
Effect of an NK1/NK2 Receptor Antagonist on Airway Responses and Inflammation to Allergen in Asthma.
Published in:
American Journal of Respiratory & Critical Care Medicine, 2007, v. 175, n. 5, p. 450, doi. 10.1164/rccm.200608-1186OC
By:
- Boot, Johan D.;
- de Haas, Sanne;
- Tarasevych, Svetlana;
- Roy, Christine;
- Wang, Lin;
- Amin, Dilip;
- Cohen, Judith;
- Sterk, Peter J.;
- Miller, Barry;
- Paccaly, Anne;
- Burggraaf, Jacobus;
- Cohen, Adam F.;
- Diamant, Zuzana
Publication type:
Article
Adjuvant trastuzumab emtansine in HER2-positive breast cancer patients with HER2-negative residual invasive disease in KATHERINE.
Published in:
NPJ Breast Cancer, 2022, v. 8, n. 1, p. 1, doi. 10.1038/s41523-022-00477-z
By:
- Loibl, Sibylle;
- Huang, Chiun-Sheng;
- Mano, Max S.;
- Mamounas, Eleftherios P.;
- Geyer Jr, Charles E.;
- Untch, Michael;
- Thery, Jean-Christophe;
- Schwaner, Ingo;
- Limentani, Steven;
- Loman, Niklas;
- Lübbe, Kristina;
- Chang, Jenny C.;
- Hatschek, Thomas;
- Tesarowski, David;
- Song, Chunyan;
- Lysbet de Haas, Sanne;
- Boulet, Thomas;
- Lambertini, Chiara;
- Wolmark, Norman
Publication type:
Article
BERENICE Final Analysis: Cardiac Safety Study of Neoadjuvant Pertuzumab, Trastuzumab, and Chemotherapy Followed by Adjuvant Pertuzumab and Trastuzumab in HER2-Positive Early Breast Cancer.
Published in:
Cancers, 2022, v. 14, n. 11, p. 2596, doi. 10.3390/cancers14112596
By:
- Dang, Chau;
- Ewer, Michael S.;
- Delaloge, Suzette;
- Ferrero, Jean-Marc;
- Colomer, Ramon;
- de la Cruz-Merino, Luis;
- Werner, Theresa L.;
- Dadswell, Katherine;
- Verrill, Mark;
- Eiger, Daniel;
- Sarkar, Sriparna;
- de Haas, Sanne Lysbet;
- Restuccia, Eleonora;
- Swain, Sandra M.
Publication type:
Article
Immune Markers and Tumor-Related Processes Predict Neoadjuvant Therapy Response in the WSG-ADAPT HER2-Positive/Hormone Receptor-Positive Trial in Early Breast Cancer.
Published in:
Cancers, 2021, v. 13, n. 19, p. 4884, doi. 10.3390/cancers13194884
By:
- Harbeck, Nadia;
- von Schumann, Raquel;
- Kates, Ronald Ernest;
- Braun, Michael;
- Kuemmel, Sherko;
- Schumacher, Claudia;
- Potenberg, Jochem;
- Malter, Wolfram;
- Augustin, Doris;
- Aktas, Bahriye;
- Forstbauer, Helmut;
- Tio, Joke;
- Grischke, Eva-Maria;
- Biehl, Claudia;
- Liedtke, Cornelia;
- De Haas, Sanne Lysbet;
- Deurloo, Regula;
- Wuerstlein, Rachel;
- Kreipe, Hans Heinrich;
- Gluz, Oleg
Publication type:
Article
Subjective Sleep Disturbance in Patients with Partial Epilepsy: A Questionnaire-based Study on Prevalence and Impact on Quality of Life.
Published in:
Epilepsia (Series 4), 2004, v. 45, n. 11, p. 1397, doi. 10.1111/j.0013-9580.2004.46703.x
By:
- de Weerd, Al;
- de Haas, Sanne;
- Otte, Andreas;
- Trenité, Dorothée Kasteleijn-Nolst;
- van Erp, Gerard;
- Cohen, Adam;
- de Kam, Marieke;
- van Gerven, Joop
Publication type:
Article
Trastuzumab emtansine with or without pertuzumab versus trastuzumab with taxane for human epidermal growth factor receptor 2-positive advanced breast cancer: Final results from MARIANNE.
Published in:
2019
By:
- Perez, Edith A.;
- Barrios, Carlos;
- Eiermann, Wolfgang;
- Toi, Masakazu;
- Im, Young‐Hyuck;
- Conte, Pierfranco;
- Martin, Miguel;
- Pienkowski, Tadeusz;
- Pivot, Xavier B.;
- Burris, Howard A.;
- Petersen, Jennifer A.;
- De Haas, Sanne;
- Hoersch, Silke;
- Patre, Monika;
- Ellis, Paul Anthony;
- Im, Young-Hyuck;
- Burris, Howard A 3rd
Publication type:
journal article
Relationship between tumor biomarkers and efficacy in TH3RESA, a phase III study of trastuzumab emtansine (T-DM1) vs. treatment of physician's choice in previously treated HER2-positive advanced breast cancer.
Published in:
International Journal of Cancer, 2016, v. 139, n. 10, p. 2336, doi. 10.1002/ijc.30276
By:
- Kim, Sung‐Bae;
- Wildiers, Hans;
- Krop, Ian E.;
- Smitt, Melanie;
- Yu, Ron;
- Lysbet de Haas, Sanne;
- Gonzalez‐Martin, Antonio
Publication type:
Article
Tumor biomarkers and efficacy in patients treated with trastuzumab emtansine + pertuzumab versus standard of care in HER2-positive early breast cancer: an open-label, phase III study (KRISTINE).
Published in:
Breast Cancer Research, 2023, v. 25, n. 1, p. 1, doi. 10.1186/s13058-022-01587-z
By:
- de Haas, Sanne L.;
- Slamon, Dennis J.;
- Martin, Miguel;
- Press, Michael F.;
- Lewis, Gail D.;
- Lambertini, Chiara;
- Prat, Aleix;
- Lopez-Valverde, Vanesa;
- Boulet, Thomas;
- Hurvitz, Sara A.
Publication type:
Article
Correction to: Relationship between tumor biomarkers and efficacy in MARIANNE, a phase III study of trastuzumab emtansine ± pertuzumab versus trastuzumab plus taxane in HER2-positive advanced breast cancer.
Published in:
2019
By:
- Perez, Edith A.;
- de Haas, Sanne Lysbet;
- Eiermann, Wolfgang;
- Barrios, Carlos H.;
- Toi, Masakazu;
- Im, Young-Hyuck;
- Conte, Pier Franco;
- Martin, Miguel;
- Pienkowski, Tadeusz;
- Pivot, Xavier B.;
- Burris III, Howard A.;
- Stanzel, Sven;
- Patre, Monika;
- Ellis, Paul Anthony;
- Burris, Howard A 3rd
Publication type:
journal article
Relationship between tumor biomarkers and efficacy in MARIANNE, a phase III study of trastuzumab emtansine ± pertuzumab versus trastuzumab plus taxane in HER2-positive advanced breast cancer.
Published in:
2019
By:
- Perez, Edith A.;
- de Haas, Sanne Lysbet;
- Eiermann, Wolfgang;
- Barrios, Carlos H.;
- Toi, Masakazu;
- Im, Young-Hyuck;
- Conte, Pier Franco;
- Martin, Miguel;
- Pienkowski, Tadeusz;
- Pivot, Xavier B.;
- Burris III, Howard A.;
- Stanzel, Sven;
- Patre, Monika;
- Ellis, Paul Anthony;
- Burris, Howard A 3rd
Publication type:
journal article
Biomarker analysis of the GATSBY study of trastuzumab emtansine versus a taxane in previously treated HER2-positive advanced gastric/gastroesophageal junction cancer.
Published in:
Gastric Cancer, 2019, v. 22, n. 4, p. 803, doi. 10.1007/s10120-018-00923-7
By:
- Shah, Manish A.;
- Kang, Yoon-Koo;
- Thuss-Patience, Peter C.;
- Ohtsu, Atsushi;
- Ajani, Jaffer A.;
- Van Cutsem, Eric;
- Hoersch, Silke;
- Harle-Yge, Marie-Laurence;
- de Haas, Sanne Lysbet
Publication type:
Article
High plasma concentrations of human urotensin II do not alter local or systemic hemodynamics in man
Published in:
Cardiovascular Research, 2002, v. 53, n. 2, p. 341, doi. 10.1016/S0008-6363(01)00485-0
By:
- Wilkinson, Ian B.;
- Affolter, Jonathan T.;
- de Haas, Sanne L.;
- Paola Pellegrini, M.;
- Boyd, Judith;
- Winter, Matthew J.;
- Balment, Richard J.;
- Webb, David J.
Publication type:
Article
89Zr-Bevacizumab PET Visualizes Heterogeneous Tracer Accumulation in Tumor Lesions of Renal Cell Carcinoma Patients and Differential Effects of Antiangiogenic Treatment.
Published in:
Journal of Nuclear Medicine, 2015, v. 56, n. 1, p. 63, doi. 10.2967/jnumed.114.144840
By:
- Oosting, Sjoukje F.;
- Brouwers, Adrienne H.;
- van Es, Suzanne C.;
- Nagengast, Wouter B.;
- Munnink, Thijs H. Oude;
- Lub-de Hooge, Marjolijn N.;
- Hollema, Harry;
- de Jong, Johan R.;
- de Jong, Igle J.;
- de Haas, Sanne;
- Scherer, Stefan J.;
- Sluiter, Wim J.;
- Dierckx, Rudi A.;
- Bongaerts, Alfons H. H.;
- Gietema, Jourik A.;
- de Vries, Elisabeth G. E.
Publication type:
Article
Orexin receptor antagonism: an ascending multiple-dose study with almorexant.
Published in:
Journal of Psychopharmacology, 2012, v. 26, n. 8, p. 1071, doi. 10.1177/0269881112448946
By:
- Hoever, Petra;
- de Haas, Sanne L;
- Dorffner, Georg;
- Chiossi, Eleonora;
- van Gerven, Joop M;
- Dingemanse, Jasper
Publication type:
Article

Found: 16

Promotion of sleep by targeting the orexin system in rats, dogs and humans.

An Overview of the CNS-Pharmacodynamic Profiles of Nonselective and Selective GABA Agonists.

Effect of an NK<sub>1</sub>/NK<sub>2</sub> Receptor Antagonist on Airway Responses and Inflammation to Allergen in Asthma.

Adjuvant trastuzumab emtansine in HER2-positive breast cancer patients with HER2-negative residual invasive disease in KATHERINE.

BERENICE Final Analysis: Cardiac Safety Study of Neoadjuvant Pertuzumab, Trastuzumab, and Chemotherapy Followed by Adjuvant Pertuzumab and Trastuzumab in HER2-Positive Early Breast Cancer.

Immune Markers and Tumor-Related Processes Predict Neoadjuvant Therapy Response in the WSG-ADAPT HER2-Positive/Hormone Receptor-Positive Trial in Early Breast Cancer.

Subjective Sleep Disturbance in Patients with Partial Epilepsy: A Questionnaire-based Study on Prevalence and Impact on Quality of Life.

Trastuzumab emtansine with or without pertuzumab versus trastuzumab with taxane for human epidermal growth factor receptor 2-positive advanced breast cancer: Final results from MARIANNE.

Relationship between tumor biomarkers and efficacy in TH3RESA, a phase III study of trastuzumab emtansine (T-DM1) vs. treatment of physician's choice in previously treated HER2-positive advanced breast cancer.

Tumor biomarkers and efficacy in patients treated with trastuzumab emtansine + pertuzumab versus standard of care in HER2-positive early breast cancer: an open-label, phase III study (KRISTINE).

Correction to: Relationship between tumor biomarkers and efficacy in MARIANNE, a phase III study of trastuzumab emtansine ± pertuzumab versus trastuzumab plus taxane in HER2-positive advanced breast cancer.

Relationship between tumor biomarkers and efficacy in MARIANNE, a phase III study of trastuzumab emtansine ± pertuzumab versus trastuzumab plus taxane in HER2-positive advanced breast cancer.

Biomarker analysis of the GATSBY study of trastuzumab emtansine versus a taxane in previously treated HER2-positive advanced gastric/gastroesophageal junction cancer.

High plasma concentrations of human urotensin II do not alter local or systemic hemodynamics in man

<sup>89</sup>Zr-Bevacizumab PET Visualizes Heterogeneous Tracer Accumulation in Tumor Lesions of Renal Cell Carcinoma Patients and Differential Effects of Antiangiogenic Treatment.

Orexin receptor antagonism: an ascending multiple-dose study with almorexant.